Add To Watchlist

BARR-PHARMACEUTICALS

The Wire

Cephalon, Barr settle Fentora dispute

Cephalon Inc. will give Barr Pharmaceuticals Inc. a license to sell a generic version of the pain drug Fentora in 2018 as part of a patent lawsuit settlement, according to a Securities and Exchange Commission filing Thursday.

Watson gets approval for emergency contraceptive

Watson Pharmaceuticals Inc. said Friday it received Food and Drug Administration approval for its over-the-counter version of the emergency contraceptive Plan B, which is made by Barr Pharmaceuticals unit Duramed.

Teva to buy Barr Pharma for more than $7 billion

Teva Pharmaceutical said Friday it will buy rival generic drugmaker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drugmaker.

The Vine
Israel's Teva buys US copycat drug rival for $7.5bn
Source: Guardian Unlimited

The global leader in copycat drugs, Teva Pharmaceuticals, is taking over a US rival, Barr Pharmaceuticals, in a $7.5bn deal which continues a rapid spate of consolidation in the crowded industry for generic medicines.

FDA Approves Pill to End Periods
Source: msnbc.com

Updated: 8:14 p.m. ET May 22, 2007 WASHINGTON - The first birth-control pill meant to put a stop to women's monthly periods indefinitely won federal approval Tuesday.

This area needs news. Click here to seed the vine